TRADING UPDATES: Sondrel wins USD23 million contract
27th Feb 2024 14:18
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Announces strategic alliance with KPMG LLC, which provides tax, audit and advisory services and commercialisation solutions for life sciences and healthcare companies. Diaceutics says the partnership will facilitate joint marketing of commercialisation solutions to life science customers for commercialisation of precision medicines. Read More
(Alliance News) - Diaceutics PLC on Tuesday highlighted the extent of market opportunities for its product, after seeing annual revenue rise despite tough macroeconomic conditions. Read More
(Alliance News) - Diaceutics PLC on Tuesday reported strong revenue growth in its first half despite a widened loss, as well as strong demand from new customers despite a cautious atmosphere in the pharmaceutical sector. Read More
Diaceutics PLC - Belfast-based testing laboratories company - Launches daily alerts update for its DXRX Signal platform, which it says will allow clients to identify patients who previously weren't receiving "the most appropriate treatment" due to lack of timely data. Adds that it has identified over 46,000 patients this year for its biopharma clients. Read More
(Alliance News) - Diaceutics PLC on Tuesday reaffirmed its full year outlook, after delivering revenue growth of 32% in the first six months of the year. Read More
Diaceutics PLC - Belfast-based testing laboratories company - Wins a three-year enterprise contract with an unnamed "top 10 global pharmaceutical company" based in the US. Says the contract will bring in USD10.1 million in revenue over its term, with options to "significantly" increase its scope and value. Revenue will be recognised monthly, with immediate effect. Says revenue will be recognised on a monthly basis. It will deliver a range of subscription data services via its DXRX platform. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News: Read More
Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP19.5 million for 2022, up 40% from GBP13.9 million in 2021. Pretax profit is GBP564,000, up from GBP462,000, as operating profit increases to GBP575,000 from GBP550,000 a year earlier. Administrative expenses increase to GBP16.3 million from GBP11.9 million. Earnings before interest, tax, depreciation and amortisation amounts to GBP3.6 million, up from GBP2.3 million. Order book stands at GBP16.9 million at year-end, compared to GBP1.8 million a year earlier. Read More
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP7.5 million for the six months that ended on June 30, up 25% from GBP6.0 million a year earlier. Says more than 75% of revenue generated through the company's DXRX platform, up 60% from 2021. Diaceutics says half-year revenue and order book growth are in line with expectations. Read More
(Alliance News) - Diaceutics PLC on Monday it will deliver customised data insights to a "top five global" pharmaceutical firm under a new contract. Read More
Diaceutics PLC - UK testing laboratories company - Announces "significant enhancements" to its DXRX platform in order to improve user experience. Company says customers will now be able to access three new AI-powered tools to ensure medicines get to patients quicker. Read More
Diaceutics PLC - UK testing laboratories company - Wins five-year contract worth at least USD1 million with an unnamed "top 30 global" pharmaceutical company, in a multi-product subscription for customised data insights via its DXRX platform. Contract expands existing relationship with the company, and sets stage for future opportunities, it says. Says its offering of customised biomarket test results and interpretation was a key draw for the client, with the client's needs in oncology to be served by DXRX Signal. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Diaceutics PLC said on Tuesday it swung to a pretax profit in 2021 and posted an increase in annual revenue. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More